TECH
Bio-Techne Corporation
Stock
$72.400.00 (0.00%)Close Oct 2, 2026
Cash flow statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $292M | $288M | $299M | $254M | $325M | $352M | $205M | $182M | $170M | $144M | $144M | $139M | $137M | $124M | $127M | $127M | $111M | $111M |
| Capital expenditures | $29M | $31M | $63M | $38M | $45M | $44M | $52M | $25M | $21M | $15M | $17M | $20M | $14M | $22M | $6.0M | $3.6M | $4.6M | $6.6M |
| Free cash flow | $263M | $257M | $236M | $216M | $280M | $308M | $153M | $156M | $149M | $129M | $127M | $119M | $123M | $101M | $121M | $124M | $107M | $105M |
| Stock-based compensation | $41M | $41M | $38M | $39M | $42M | $49M | $32M | $32M | $28M | $15M | $9.4M | $6.0M | $3.5M | $1.9M | — | $1.1M | $1.1M | $1.5M |
| Buybacks | $42M | $276M | $80M | $20M | $161M | $43M | $50M | $15M | $0 | — | — | $0 | $0 | $1.8M | $24M | $1.9M | $15M | $91M |
| Dividends paid | $50M | $50M | $50M | $50M | $50M | $50M | $49M | $48M | $48M | $47M | $48M | $47M | $45M | $43M | $41M | $40M | $38M | $28M |
| Dividends per share | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.31 | $0.30 | $0.28 | $0.27 | $0.26 | $0.19 |
| Free cash flow margin | 21.7% | 21.0% | 20.4% | 19.0% | 25.4% | 33.1% | 20.8% | 21.9% | 23.2% | 22.8% | 25.5% | 26.4% | 34.4% | 32.6% | 38.4% | 42.6% | 39.6% | 39.7% |